Latest News and Press Releases

Myriad Genetics announced a collaboration with Gabbi to provide an integrated offering for breast cancer risk assessment.

Myriad Genetics and CancerCARE for Life announced an agreement designed to enhance education and access to hereditary cancer testing.

Myriad Genetics announced a hereditary cancer risk assessment program study was published in Obstetrics & Gynecology (also known as The Green Journal).

Myriad Genetics announced it signed an agreement with sports broadcaster Hannah Storm to promote the importance of knowing family cancer history.

Myriad Genetics announced a MyRisk® Hereditary Cancer Test with RiskScore® study was named as one of the top 10 significant advances in genomic medicine.

Myriad Genetics’ full suite of urologic oncology products is elevated by updated NCCN prostate cancer guidelines.

Myriad Genetics, Inc. announced it will present new data at the 2024 San Antonio Breast Cancer Symposium.

SALT LAKE CITY, July 17, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced results from its nationwide Cancer Risk...